Massive Bio: Advancing Cancer Care with AI-Driven Clinical Trials
As a pioneer in oncological and hematological innovation, Massive Bio is showcasing its groundbreaking AI technology at the ASCO...
Lokavant Expands Team to Enhance AI-Driven Clinical Trial Feasibility Solution
Lokavant, a clinical trial intelligence platform, has strengthened its team with the appointment of three new Advisory Board members...
Neurogene Unveils Remarkable Trial Results in Rett Syndrome
Neurogene Inc. has reported positive initial safety and tolerability data from its ongoing Phase 1/2 gene therapy trial for...
AI Predicts Metastasis Risk in Prostate Cancer: Revolutionary Biomarker
ArteraAI has announced the validation of its AI-based digital pathology biomarker for predicting metastasis risk in prostate cancer patients...
Cybin Unveils Strategies For CYB003 & CYB004 Psychedelic Drug Development
Cybin Inc., a biopharmaceutical company specializing in psychedelic-based mental health treatments, has secured $150 million in funding to advance...
Xeris & Beta Bionics Partner for Liquid Glucagon Development
Xeris Biopharma and Beta Bionics have entered into an exclusive worldwide collaboration and license agreement to develop and commercialize...
BMS Submits EMA Application for Opdivo and Yervoy for mCRC
Bristol Myers Squibb (BMS) recently submitted an application to the European Medicines Agency (EMA) for the use of the...
Unlock the Doors of Health Equity: Walgreens and Boehringer Ingelheim’s Partnership
Boehringer Ingelheim and Walgreens have joined forces to revolutionize clinical trials. Through this collaboration, people with obesity, overweight, and...
MCL Treatment Revolution: Calquence Powers Progression-Free Life
A promising new treatment option has emerged for patients with mantle cell lymphoma (MCL), a rare and aggressive type...
NIAID Awards $14M for Institutional Review Services to Advarra
The National Institutes of Health (NIH) has chosen Advarra as its exclusive single institutional review board (sIRB) for clinical...